{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:187",
      "entity_text" : "acetylcholine",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ05426",
      "entity_text" : "muscarinic receptors",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "It is a competitive antagonist of the muscarinic receptors, thereby inhibiting the effect of acetylcholine, a major neurotransmitter of the parasympathetic nervous system, also innervating the submandibular glands18 For example, atropine is used to prevent or treat cholinergic effects during operations by excessive vagal stimulation, or to slow down the unwanted muscarinic effects of drugs.19 Orally administered atropine appears safe and well tolerated up to doses of 0.03mg / kg.",
  "reading_complete" : "2020-08-03T16:04:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:03:46Z",
  "trigger" : "inhibiting",
  "evidence" : [ "muscarinic receptors, thereby inhibiting the effect of acetylcholine" ],
  "pmc_id" : "6878073",
  "score" : 0
}